Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization

Coronary Artery Disease

Volumn 17, Issue 5, 2006, Pages 419-423

  Palazzuoli, Alberto ^a   Poldermans, Don ^b   Capobianco, Stefano ^a   Giannotti, Giovanna ^a   Iovine, Francesca ^a   Campagna, Maria Stella ^a   Calabrò, Anna ^a   Bagaglia, Simone ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brain natriuretic peptide; Coronary disease; Myocardial ischemia; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; NITRATE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CATHETERIZATION; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY BLOOD VESSEL; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENDER; GROUPS BY AGE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; ISCHEMIA; MALE; MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 33748183183     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200608000-00004     Document Type: Article

References (30)

1. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87:464-469.
2. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90:195-203.
3. Levin ER, Gardner DG, Samson WK. Natriuretic peptides [Review]. N Engl J Med 1998; 339:321-328.
4. Clerico A, lervasi G, Pilo A. Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations [Review]. Curr Drug Metab 2000; 1:85-105.
5. Cheung BMY, Kumana CR. Natriuretic peptides - relevance in cardiovascular disease. JAMA 1998; 280:1983-1984.
6. Luchner A, Burnett JC, Jougasaki M, Hense HW, Heid IM, Muders F, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 2000; 18:1121-1128.
7. Arakawa N, Nakamura M, Aoki H, Hiramori K. Relationship between plasma levels of brain natriuretic peptide and myocardial infarct size. Cardiology 1994; 85:334-340.
8. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch) 1995; 88:551-556.
9. Darbar D, Davidson NC, Gillespie N, Choy AM, Lang CC, Shyr Y, et al. Diagnostic value of B-type natriuretic peptide concentration in patients with acute myocardial infarction. Am J Cardiol 1996; 78:284-287.
10. Arakawa N, Nakamura M, Aoki H, Kiramori K. Plasma brain natriuretic peptide concentration predicts survival after acute MI. J Am Coll Cardiol 1996; 27:1656-1661.
11. Rutherford JD, Braunwald E. Coronary heart disease. In: Braunwald E, editor. Heart diseases. Vol. 2. 5th ed. Philadelphia, USA: Saunders Co; 1997. pp. 1799-1869.
12. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999; 100:1593-1601.
13. Wahr DW, Wang YS, Shiller NB. Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population. J Am Coll Cardiol 1983; 1:863-868.
14. Paavo U, Heikki R, Olii V, Matti N, Jarmo L, Markku I, et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction. Int J Cardiol 1999; 69:5-14.
15. White M, Rouleau JL, Hall C, Arnold M, Harel F, Sirois P, et al. Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodelling soon after anterior myocardial infarction. Am Heart J 2001; 142:1056-1064.
16. Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner JG, et al. Neuroendocrine prediction of left ventricular function and heart failure after myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart 1999; 81:114-120.
17. Mair P, Mair J, Bleier J, Hormann C, Balogh D, Puschendorf B. Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest. Clin Chim Acta 1997; 261:57-68.
18. Nakao K, Mukoyama M, Hosoda K, Suga S, Ogawa Y, Saito Y, et al. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. Can J Physiol Pharmacol 1991; 69:1500-1506.
19. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart 2001; 86:638-642.
20. Talwar S, Squire IB, Downie PF, Davies JE, Ng LL. Plasma N-terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 2000; 84:421-424.
21. Sahinarslan A, Cengel A, Okyay K, Yazc HU, Elbey S, Cemri M, et al. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease. Coron Artery Dis 2005; 16:225-229.
22. Avidan MS, Meehan N, Ponte J, Gamel AE, Sheerwood R. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta 2001; 303:127-132.
23. Selvais PL, Donckier JE, Robert A, Laloux O, Van Linden O, Ahn S, et al. Cardiac natriuretic peptide for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary disease on cardiac hormonal activation. Eur J Clin Invest 1998; 28:636-642.
24. Foote RS, Pearlman JD, Siegel AH, Yeo KT. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2004; 16:1980-1987.
25. Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida H, Kato H, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996; 132:101-107.
26. Jernberg T, Stridsberg M, Venge P, Lindahl B. N terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and non-ST segment elevation. J Am Coll Cardiol 2002; 40:437-445.
27. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345:1014-1021.
28. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44:564-568.
29. Sabatine MS, Morrow DA, De Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Circulation 2002; 105:1760-1763.
30. White HD, French JK. Use of brain natriuretic peptide levels for risk assessment in non ST-elevation acute coronary syndromes. J Am Coll Cardiol 2003; 42:1909-1916.